Verrica Pharmaceuticals Inc.

VRCAReported to SECin USCIK 0001660334Filings at SEC EDGAR

No score on this page, by design. Everything here is a fact from a public U.S. register: insider filings at the SEC (Form 4), lobbying filings under the Lobbying Disclosure Act, trades reported by members of Congress under the STOCK Act, and fund holdings in 13F filings. Our scores, percentiles and signals run on the Dutch register only, because that is the only register the model has been validated on.

This page is free to read, and it stops after 5 rows. Those are the 5 most recent Form 4 lines at this company, out of 6. Reading the whole list, and the full version of each filer's page, is part of the subscription. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

The most recent filings

Most recent filing first: every line of every Form 4 at this company that passed our review, the same lines as on the register. Reported is the day the filing reached the SEC, usually within two business days of the trade. Amounts are in U.S. dollars, as the form states them.

5 of 6
Form 4 lines at Verrica Pharmaceuticals Inc., most recent filing first
Filed byTypeValueReportedFiled byValueTypeSharesReported
Zawitz DavidChief Operating OfficerOpen-market buy$29,8806,000 sharesAug 18, 2026Zawitz DavidChief Operating Officer$29,880Buy · Aug 18Open-market buy6,000Aug 18, 2026
Rieger JaysonCEO and PresidentOpen-market buy$24,5505,000 sharesAug 18, 2026Rieger JaysonCEO and President$24,550Buy · Aug 18Open-market buy5,000Aug 18, 2026
Rieger JaysonCEO and PresidentOpen-market buy$101,20020,000 sharesAug 18, 2026Rieger JaysonCEO and President$101,200Buy · Aug 18Open-market buy20,000Aug 18, 2026
Rosenberg Noah L.CMOOpen-market buy$9,9882,030 sharesAug 18, 2026Rosenberg Noah L.CMO$9,988Buy · Aug 18Open-market buy2,030Aug 18, 2026
Rosenberg Noah L.CMOOpen-market buy$20,6224,200 sharesAug 18, 2026Rosenberg Noah L.CMO$20,622Buy · Aug 18Open-market buy4,200Aug 18, 2026